Log in or Sign up for Free to view tailored content for your specialty!
COPD News
GOLD International COPD Conference to cover spirometry, treatments, multimorbidity
The 2024 GOLD International COPD Conference will be held Nov. 11 and 12 in Philadelphia and online, featuring presentations from various speakers on important topics pertaining to COPD care.
COPD-related health care usage drops with ensifentrine in moderate to severe COPD
BOSTON — Fewer patients with moderate to severe COPD used health care resources related to the disease if they received ensifentrine for 48 weeks, according to a presentation at the CHEST Annual Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: Monitoring pulmonary diseases, lung function at home via smartphone
Patients with COPD, asthma and cystic fibrosis may soon be able to monitor their diseases by using/breathing through a tool that connects to their smartphone, according to a University of Pittsburgh press release.
Costs, health care utilization rise after patients with COPD become frequent exacerbators
BOSTON — After progressing to Global Initiative for Chronic Obstructive Lung Disease, or GOLD, group E, patients with COPD faced higher costs and used health care resources more, according to a poster presented at the CHEST Annual Meeting.
Ensifentrine improves outcomes in both moderate, severe COPD
BOSTON — Lung function, symptoms and quality of life improved with receipt of ensifentrine in both adults with moderate COPD and adults with severe COPD, according to data presented at the CHEST Annual Meeting.
GLP-1 agonists may improve respiratory outcomes among patients with COPD, type 2 diabetes
BOSTON — Patients with both COPD and type 2 diabetes who used GLP-1 agonists or co-agonists had improved respiratory outcomes vs. those who used other type 2 diabetes medications, according to data presented at the CHEST Annual Meeting.
Health information technology tools improve pneumonia vaccination rates in COPD patients
BOSTON — Researchers found an incremental association between the usage of health information technology and pneumococcal vaccine uptake among patients with COPD, according to data presented at the CHEST Annual Meeting.
Common muscle relaxants associated with increased COPD exacerbation risk
BOSTON — Patients with COPD using the common muscle relaxants cyclobenzaprine or methocarbamol had increased risk for COPD exacerbations at follow-up, according to data presented at the CHEST Annual Meeting.
Single vs. multiple inhaler COPD triple therapy decreases risk of cardiopulmonary events
BOSTON — Patients with COPD faced a decreased risk of severe cardiopulmonary events if treated with single inhaler vs. multiple inhaler triple therapy, according to data presented at the CHEST Annual Meeting.
Likelihood for cardiovascular diseases reduced in bronchiectasis vs. COPD
Fewer patients with bronchiectasis vs. COPD had at least one cardiovascular comorbidity/risk factor, according to results published in Respiratory Medicine.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read